Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital
Antifungal stewardship (AFS), compared with antimicrobial stewardship (AS), requires more advanced knowledge, skills, and multidisciplinary collaboration in its implementation. Therefore, fewer facilities are performing AFS compared with AS. At our hospital, we started AS and AFS in 2014. Our AFS pr...
Gespeichert in:
| Veröffentlicht in: | Medical Mycology Journal 2024/04/30, Vol.65(2), pp.33-38 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 38 |
|---|---|
| container_issue | 2 |
| container_start_page | 33 |
| container_title | Medical Mycology Journal |
| container_volume | 65 |
| creator | Yamada, Koichi Kakeya, Hiroshi |
| description | Antifungal stewardship (AFS), compared with antimicrobial stewardship (AS), requires more advanced knowledge, skills, and multidisciplinary collaboration in its implementation. Therefore, fewer facilities are performing AFS compared with AS. At our hospital, we started AS and AFS in 2014. Our AFS programs include the following: i) interventions for patients with yeast-positive blood cultures, ii) introduction of a conditional antifungal notification system, and iii) commencement of AS team rounds. AFS for filamentous fungi includes bronchoscopy and microbial identification, including genetic and drug susceptibility testing. These AFS activities have improved several processes and outcome measures. However, our AFS team has faced several problems owing to the impact of COVID-19. This review introduces the practice of AFS, which we initiated at our hospital in 2014, and presents the current problems. |
| doi_str_mv | 10.3314/mmj.24.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3104745600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3104745600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-a6f324177fcc12dadbd1eb21f39da7f082f25c728737afcba8fb6b25ae2129f93</originalsourceid><addsrcrecordid>eNo9kE1Lw0AQhhdRrNRe_AGy4E1IzX4mBS-lqBUqPdSCB2GZJLtNaprE3Y3Sf2_6YecwMwwP78CD0A0Jh4wR_rDZrIeUD8OQnaErSmIZECk-zve7CCSPZQ8NnFuHXQlJRoReoh6LYyoEja_Q58KDbx2GKsOTHMpSVyuNa4PHlS9MW62gxAuvf8FmLi8aDB77XOO5gy_Ab9rbuqnLwkOFl1Xxo60r_BZPa9d0t_IaXRgonR4cZx8tn5_eJ9NgNn95nYxnQco58wFIwygnUWTSlNAMsiQjOqHEsFEGkQljaqhIIxpHLAKTJhCbRCZUgKaEjsyI9dHdIbex9XernVfrurVV91IxEvKIC9n56aP7A5Xa2jmrjWpssQG7VSRUO5eqc6koVx3bwbfHyDbZ6OyE_pvrgMcDsHYeVvoEgPVFWup9lhSK7hpjp3Oag1W6Yn-PDoZ1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3104745600</pqid></control><display><type>article</type><title>Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital</title><source>J-STAGE (Free - Japanese)</source><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Yamada, Koichi ; Kakeya, Hiroshi</creator><creatorcontrib>Yamada, Koichi ; Kakeya, Hiroshi</creatorcontrib><description>Antifungal stewardship (AFS), compared with antimicrobial stewardship (AS), requires more advanced knowledge, skills, and multidisciplinary collaboration in its implementation. Therefore, fewer facilities are performing AFS compared with AS. At our hospital, we started AS and AFS in 2014. Our AFS programs include the following: i) interventions for patients with yeast-positive blood cultures, ii) introduction of a conditional antifungal notification system, and iii) commencement of AS team rounds. AFS for filamentous fungi includes bronchoscopy and microbial identification, including genetic and drug susceptibility testing. These AFS activities have improved several processes and outcome measures. However, our AFS team has faced several problems owing to the impact of COVID-19. This review introduces the practice of AFS, which we initiated at our hospital in 2014, and presents the current problems.</description><identifier>ISSN: 2185-6486</identifier><identifier>EISSN: 2186-165X</identifier><identifier>EISSN: 1882-0476</identifier><identifier>DOI: 10.3314/mmj.24.003</identifier><identifier>PMID: 38825528</identifier><language>eng</language><publisher>Japan: The Japanese Society for Medical Mycology</publisher><subject>Antifungal Agents - pharmacology ; Antifungal Agents - therapeutic use ; antifungal stewardship ; Antimicrobial Stewardship - methods ; Bronchoscopy ; bundle ; COVID-19 ; handshake stewardship ; Hospitals, University ; Humans ; Japan ; Mycoses - drug therapy ; SARS-CoV-2 - drug effects ; susceptibility testing ; task shifting</subject><ispartof>Medical Mycology Journal, 2024/04/30, Vol.65(2), pp.33-38</ispartof><rights>2024 The Japanese Society for Medical Mycology</rights><rights>Copyright Japan Science and Technology Agency 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c443t-a6f324177fcc12dadbd1eb21f39da7f082f25c728737afcba8fb6b25ae2129f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38825528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Koichi</creatorcontrib><creatorcontrib>Kakeya, Hiroshi</creatorcontrib><title>Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital</title><title>Medical Mycology Journal</title><addtitle>Med Mycol J</addtitle><description>Antifungal stewardship (AFS), compared with antimicrobial stewardship (AS), requires more advanced knowledge, skills, and multidisciplinary collaboration in its implementation. Therefore, fewer facilities are performing AFS compared with AS. At our hospital, we started AS and AFS in 2014. Our AFS programs include the following: i) interventions for patients with yeast-positive blood cultures, ii) introduction of a conditional antifungal notification system, and iii) commencement of AS team rounds. AFS for filamentous fungi includes bronchoscopy and microbial identification, including genetic and drug susceptibility testing. These AFS activities have improved several processes and outcome measures. However, our AFS team has faced several problems owing to the impact of COVID-19. This review introduces the practice of AFS, which we initiated at our hospital in 2014, and presents the current problems.</description><subject>Antifungal Agents - pharmacology</subject><subject>Antifungal Agents - therapeutic use</subject><subject>antifungal stewardship</subject><subject>Antimicrobial Stewardship - methods</subject><subject>Bronchoscopy</subject><subject>bundle</subject><subject>COVID-19</subject><subject>handshake stewardship</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Japan</subject><subject>Mycoses - drug therapy</subject><subject>SARS-CoV-2 - drug effects</subject><subject>susceptibility testing</subject><subject>task shifting</subject><issn>2185-6486</issn><issn>2186-165X</issn><issn>1882-0476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1Lw0AQhhdRrNRe_AGy4E1IzX4mBS-lqBUqPdSCB2GZJLtNaprE3Y3Sf2_6YecwMwwP78CD0A0Jh4wR_rDZrIeUD8OQnaErSmIZECk-zve7CCSPZQ8NnFuHXQlJRoReoh6LYyoEja_Q58KDbx2GKsOTHMpSVyuNa4PHlS9MW62gxAuvf8FmLi8aDB77XOO5gy_Ab9rbuqnLwkOFl1Xxo60r_BZPa9d0t_IaXRgonR4cZx8tn5_eJ9NgNn95nYxnQco58wFIwygnUWTSlNAMsiQjOqHEsFEGkQljaqhIIxpHLAKTJhCbRCZUgKaEjsyI9dHdIbex9XernVfrurVV91IxEvKIC9n56aP7A5Xa2jmrjWpssQG7VSRUO5eqc6koVx3bwbfHyDbZ6OyE_pvrgMcDsHYeVvoEgPVFWup9lhSK7hpjp3Oag1W6Yn-PDoZ1</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Yamada, Koichi</creator><creator>Kakeya, Hiroshi</creator><general>The Japanese Society for Medical Mycology</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope></search><sort><creationdate>20240101</creationdate><title>Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital</title><author>Yamada, Koichi ; Kakeya, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-a6f324177fcc12dadbd1eb21f39da7f082f25c728737afcba8fb6b25ae2129f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antifungal Agents - pharmacology</topic><topic>Antifungal Agents - therapeutic use</topic><topic>antifungal stewardship</topic><topic>Antimicrobial Stewardship - methods</topic><topic>Bronchoscopy</topic><topic>bundle</topic><topic>COVID-19</topic><topic>handshake stewardship</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Japan</topic><topic>Mycoses - drug therapy</topic><topic>SARS-CoV-2 - drug effects</topic><topic>susceptibility testing</topic><topic>task shifting</topic><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Koichi</creatorcontrib><creatorcontrib>Kakeya, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Medical Mycology Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Koichi</au><au>Kakeya, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital</atitle><jtitle>Medical Mycology Journal</jtitle><addtitle>Med Mycol J</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>65</volume><issue>2</issue><spage>33</spage><epage>38</epage><pages>33-38</pages><issn>2185-6486</issn><eissn>2186-165X</eissn><eissn>1882-0476</eissn><abstract>Antifungal stewardship (AFS), compared with antimicrobial stewardship (AS), requires more advanced knowledge, skills, and multidisciplinary collaboration in its implementation. Therefore, fewer facilities are performing AFS compared with AS. At our hospital, we started AS and AFS in 2014. Our AFS programs include the following: i) interventions for patients with yeast-positive blood cultures, ii) introduction of a conditional antifungal notification system, and iii) commencement of AS team rounds. AFS for filamentous fungi includes bronchoscopy and microbial identification, including genetic and drug susceptibility testing. These AFS activities have improved several processes and outcome measures. However, our AFS team has faced several problems owing to the impact of COVID-19. This review introduces the practice of AFS, which we initiated at our hospital in 2014, and presents the current problems.</abstract><cop>Japan</cop><pub>The Japanese Society for Medical Mycology</pub><pmid>38825528</pmid><doi>10.3314/mmj.24.003</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2185-6486 |
| ispartof | Medical Mycology Journal, 2024/04/30, Vol.65(2), pp.33-38 |
| issn | 2185-6486 2186-165X 1882-0476 |
| language | eng |
| recordid | cdi_proquest_journals_3104745600 |
| source | J-STAGE (Free - Japanese); MEDLINE; Free E-Journal (出版社公開部分のみ） |
| subjects | Antifungal Agents - pharmacology Antifungal Agents - therapeutic use antifungal stewardship Antimicrobial Stewardship - methods Bronchoscopy bundle COVID-19 handshake stewardship Hospitals, University Humans Japan Mycoses - drug therapy SARS-CoV-2 - drug effects susceptibility testing task shifting |
| title | Status and Challenge of Antifungal Stewardship at the Osaka Metropolitan University Hospital |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A25%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Status%20and%20Challenge%20of%20Antifungal%20Stewardship%20at%20the%20Osaka%20Metropolitan%20University%20Hospital&rft.jtitle=Medical%20Mycology%20Journal&rft.au=Yamada,%20Koichi&rft.date=2024-01-01&rft.volume=65&rft.issue=2&rft.spage=33&rft.epage=38&rft.pages=33-38&rft.issn=2185-6486&rft.eissn=2186-165X&rft_id=info:doi/10.3314/mmj.24.003&rft_dat=%3Cproquest_cross%3E3104745600%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3104745600&rft_id=info:pmid/38825528&rfr_iscdi=true |